KANSAS CITY, Kan. and BOSTON, Feb. 5, 2013 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will present at two upcoming healthcare conferences. Steven St. Peter, M.D., President and Chief Executive Officer of Aratana Therapeutics, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with potential collaborators.
Aratana has been selected as one of a few privately held companies to present at the 2013 BIO CEO and Investor Conference, to be held February 11-12, 2013, at the Waldorf Astoria Hotel in New York.
BIO CEO and Investor Conference
Tuesday, February 12, 2013
9:45 am (Eastern Time)
Park South; Waldorf Astoria Hotel; New York
The Company will also present at the Leerink Swann Global Healthcare Conference, to be held February 13-14, 2013, also at the Waldorf Astoria Hotel.
Leerink Swann Global Healthcare Conference
Thursday, February 14, 2013
2:30 pm (Eastern Time)
Morgan Suite; Waldorf Astoria Hotel; New York
Dr. St. Peter will be joined by Louise Mawhinney, CPA, Chief Financial Officer; Linda Rhodes, V.M.D., Ph.D., Chief Scientific Officer; Julia Stephanus, Chief Commercial Officer; and Erick Lucera, Vice President, Corporate Development of Aratana Therapeutics.
About Aratana Therapeutics
Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals). Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market. For more information, please visit www.aratanatherapeutics.com.
For Investors & Media:
Joshua Drumm, Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
SOURCE Aratana Therapeutics